KROS vs CBIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 10, 2026
KROS
CBIO
Investment Advisor Scores
CBIO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | KROS | CBIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 48.7805 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -99.8% | 0.0% | CBIO |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 48.1/100 | 32.9/100 | KROS |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
KROS
MarkupPrice above SMA50, rising 50-day trend (2.0% over 20 days), RSI 52
CBIO
MarkupPrice above SMA50, rising 50-day trend (0.8% over 20 days), RSI 58
Fundamentals Snapshot
| Metric | KROS | CBIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.7 | -7.4 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -1.0% | 0.0% |
| Gross Margin | -3.9% | 1.0% |
| Operating Margin | -6.6% | -14.3% |
| EPS | -3.18 | -0.14 |
| Dividend Yield | — | — |